title: Not yet time for a paradigm shift away from angiotensin inhibitors in chronic kidney disease, but due diligence required.
authors: P A
authors: PA
authors: Swift
authors: P A
authors: PA
authors: Andrews
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D003928:Diabetic Nephropathies / Q000517:prevention & control*; D006801:Humans; D007674:Kidney Diseases / Q000517:prevention & control*; D012084:Renin-Angiotensin System / Q000187:drug effects*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors